QTEX
NasdaqQTREX Quantum Ltd.
Technology · Surgical & Medical Instruments & Apparatus
Research view
Fundamentals · SEC EDGAR · FY 2025-12-31
Revenue & Earnings — fiscal year
🔒 price chart needs market-data feed$0
2023
$0
2024
$289,000
2025
Snapshot
SEC EDGAR · FY 2025-12-31Revenue$289,000
Net Income$-13.2M
Gross Profit$2,000
Oper Income$-13.6M
EPS (dil)$-0.45
Rev/sh$0.01
FCF/sh$-0.28
Book/sh$0.06
Gross M0.7%
Oper M-4713.8%
Profit M-4574.4%
FCF M-3447.8%
ROE-569.1%
ROA-247.5%
ROIC—
R&D/Rev2593.8%
Rev Y/Y—
Rev 3Y CAGR—
EPS Y/Y25.0%
EPS 3Y CAGR—
FCF 3Y CAGR—
Payout—
Div/sh—
Shs Chg Y/Y+60%
Current Ratio1.56
Quick Ratio1.30
Debt/Eq—
Int Coverage-11.7×
Net Debt—
Total Debt—
Cash & Eq$3.3M
Total Assets$5.3M
Oper CF$-9.9M
Capex$103,000
Free CF$-10.0M
Buybacks—
Equity$2.3M
Liabilities—
Shs Outstand0.04B
SectorTechnology
🔒 P/E—
🔒 Fwd P/E—
🔒 P/S—
🔒 P/B—
🔒 Market Cap—
🔒 Div Yield—
🔒 52W Range—
🔒 Beta—
40+ fundamentals — free from SEC EDGAR (public domain). Only the 🔒 price-derived column needs a market-data feed.
Financials — annual
SEC EDGAR · last 3 FY| USD | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $0 | $0 | $289,000 |
| Gross Profit | $0 | $0 | $2,000 |
| Operating Income | $-12.1M | $-11.3M | $-13.6M |
| Net Income | $-11.3M | $-11.1M | $-13.2M |
| Diluted EPS | $-0.93 | $-0.60 | $-0.45 |
| Operating Cash Flow | $-9.7M | $-9.4M | $-9.9M |
| Free Cash Flow | $-9.9M | $-9.5M | $-10.0M |
COMMUNITY · $QTEX0 theses
POST YOUR TAKE →Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.